The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.
暂无分享,去创建一个
E. Jaffe | S. Swerdlow | L. Cerroni | E. Berti | F. Facchetti | R. Willemze | W. Kempf
[1] R. Willemze,et al. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type , 2018, The American journal of surgical pathology.
[2] L. Cerroni,et al. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. , 2018, The Journal of investigative dermatology.
[3] D. Elder,et al. WHO classification of skin tumours , 2018 .
[4] D. Fanoni,et al. Primary cutaneous acral CD8 positive T‐cell lymphoma with extra‐cutaneous involvement: A long‐standing case with an unexpected progression , 2017, Journal of cutaneous pathology.
[5] S. Swerdlow. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .
[6] R. Willemze,et al. Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group , 2017, The British journal of dermatology.
[7] M. Duvic,et al. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides , 2017, Archives of Dermatological Research.
[8] M. Bagot,et al. Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with Sézary Syndrome , 2017, Clinical Cancer Research.
[9] L. Pincus,et al. Primary cutaneous B-cell lymphomas with large cell predominance-primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma. , 2017, Seminars in diagnostic pathology.
[10] K. Elenitoba-Johnson,et al. A new molecular paradigm in mycosis fungoides and Sézary syndrome. , 2017, Seminars in diagnostic pathology.
[11] S. Swerdlow. Cutaneous marginal zone lymphomas. , 2017, Seminars in diagnostic pathology.
[12] W. Kempf. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders. , 2017, Seminars in diagnostic pathology.
[13] S. Ascani,et al. Primary cutaneous B‐cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers , 2016, Cancer medicine.
[14] R. Willemze,et al. Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides. , 2016, JAMA dermatology.
[15] D. Cappellen,et al. MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma. , 2016, The Journal of investigative dermatology.
[16] M. Feinmesser,et al. New insights into folliculotropic mycosis fungoides (FMF): A single-center experience. , 2016, Journal of the American Academy of Dermatology.
[17] R. Willemze,et al. No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course. , 2016, Blood.
[18] M. Felcht,et al. Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients. , 2016, The Journal of investigative dermatology.
[19] J. Merlio,et al. Sézary Syndrome: Translating Genetic Diversity into Personalized Medicine. , 2016, The Journal of investigative dermatology.
[20] M. Felcht,et al. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases , 2015, The British journal of dermatology.
[21] A. Rosenwald,et al. CD68 expression is a discriminative feature of indolent cutaneous CD8‐positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8‐positive cutaneous lymphomas , 2015, The British journal of dermatology.
[22] M. Piris,et al. Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features , 2015, Histopathology.
[23] R. Willemze,et al. Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30‐positive lymphoproliferative disease , 2015, The British journal of dermatology.
[24] A. Feldman,et al. Anaplastic Large Cell Lymphomas: ALK Positive, ALK Negative, and Primary Cutaneous , 2015, Advances in anatomic pathology.
[25] K. Elenitoba-Johnson,et al. A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders. , 2014, Blood.
[26] T. Petrella,et al. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type. , 2014, JAMA dermatology.
[27] W. Wilson,et al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. , 2014, Blood.
[28] R. Willemze,et al. Methotrexate-associated B-cell Lymphoproliferative Disorders Presenting in the Skin: A Clinicopathologic and Immunophenotypical Study of 10 Cases , 2014, The American journal of surgical pathology.
[29] S. Horwitz,et al. Multicenter Case Series of Indolent Small/Medium-Sized CD8+ Lymphoid Proliferations With Predilection for the Ear and Face , 2014, The American Journal of dermatopathology.
[30] T. Petrella,et al. Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma , 2014, Modern Pathology.
[31] W. Klapper,et al. Peripheral T‐cell and NK‐cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology , 2014, Histopathology.
[32] C. Schmidt,et al. Nuclear factor-κB pathway-activating gene aberrancies in primary cutaneous large B-cell lymphoma, leg type. , 2014, The Journal of investigative dermatology.
[33] F. Climent,et al. Primary cutaneous marginal zone B-cell lymphoma: Response to treatment and disease-free survival in a series of 137 patients , 2013 .
[34] A. Feldman,et al. Chromosomal Rearrangements of 6p25.3 Define a New Subtype of Lymphomatoid Papulosis , 2013, The American journal of surgical pathology.
[35] J. Plaza,et al. Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases. , 2013, Journal of the American Academy of Dermatology.
[36] S. Swerdlow,et al. Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. , 2013, American journal of clinical pathology.
[37] S. Swerdlow,et al. Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. , 2013, American journal of clinical pathology.
[38] M. Piris,et al. TCR-&ggr; Expression in Primary Cutaneous T-cell Lymphomas , 2013, The American journal of surgical pathology.
[39] L. Michel,et al. Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis. , 2013, Blood.
[40] T. Petrella,et al. Indolent CD8+ lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features , 2013, Journal of cutaneous pathology.
[41] T. Mentzel,et al. Angioinvasive Lymphomatoid Papulosis: A New Variant Simulating Aggressive Lymphomas , 2013, The American journal of surgical pathology.
[42] W. Klapper,et al. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study , 2013, Haematologica.
[43] R. Willemze,et al. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides. , 2012, Archives of dermatology.
[44] David I. Smith,et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. , 2012, Blood.
[45] T. Naoe,et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. , 2012, Blood.
[46] R. Willemze,et al. Expression of Programmed Death-1 in Primary Cutaneous CD4-Positive Small/Medium-Sized Pleomorphic T-Cell Lymphoma, Cutaneous Pseudo-T-Cell Lymphoma, and Other Types of Cutaneous T-Cell Lymphoma , 2012, The American journal of surgical pathology.
[47] R. Dummer,et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. , 2011, Blood.
[48] A. Feldman,et al. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies , 2011, Modern Pathology.
[49] S. Swerdlow,et al. Cutaneous Marginal Zone Lymphomas Have Distinctive Features and Include 2 Subsets , 2010, The American journal of surgical pathology.
[50] M. Piris,et al. EBV-associated Cutaneous NK/T-cell Lymphoma: Review of a Series of 14 Cases From Peru in Children and Young Adults , 2010, The American journal of surgical pathology.
[51] J. Scarisbrick,et al. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] Z. Argényi,et al. A Variant of Lymphomatoid Papulosis Simulating Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-cell Lymphoma. Description of 9 Cases , 2010, The American journal of surgical pathology.
[53] R. Willemze,et al. IgM Expression on Paraffin Sections Distinguishes Primary Cutaneous Large B-cell Lymphoma, Leg Type From Primary Cutaneous Follicle Center Lymphoma , 2010, The American journal of surgical pathology.
[54] E. Jaffe,et al. EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression , 2010, The American journal of surgical pathology.
[55] H. Kerl,et al. Primary Cutaneous CD4+ Small-/Medium-Sized Pleomorphic T-Cell Lymphoma: A Cutaneous Nodular Proliferation of Pleomorphic T Lymphocytes of Undetermined Significance? A Study of 136 Cases , 2009, The American Journal of dermatopathology.
[56] T. Petrella,et al. Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. , 2009, The Journal of investigative dermatology.
[57] E. Campo,et al. Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers , 2009, The American journal of surgical pathology.
[58] R. Bende,et al. The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment. , 2008, Blood.
[59] C. Massone,et al. The prognosis of early mycosis fungoides is not influenced by phenotype and T‐cell clonality , 2008, The British journal of dermatology.
[60] G. Pinkus,et al. Primary Cutaneous ALCL With Phosphorylated/Activated Cytoplasmic ALK and Novel Phenotype: EMA/MUC1+, Cutaneous Lymphocyte Antigen Negative , 2008, The American journal of surgical pathology.
[61] A. López-Guillermo,et al. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[62] T. Kuzel,et al. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma. , 2008, Archives of dermatology.
[63] A. Dogan,et al. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior , 2008, Modern Pathology.
[64] T. Petrella,et al. Indolent CD8-positive Lymphoid Proliferation of the Ear: A Distinct Primary Cutaneous T-cell Lymphoma? , 2007, The American journal of surgical pathology.
[65] D. Weisenburger,et al. Epstein-Barr Virus Negative Clonal Plasma Cell Proliferations and Lymphomas in Peripheral T-cell Lymphomas: A Phenomenon With Distinctive Clinicopathologic Features , 2007, The American journal of surgical pathology.
[66] T. Petrella,et al. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. , 2007, Archives of dermatology.
[67] C. Meijer,et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] Y. Tomita,et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. , 2007, The Journal of rheumatology.
[69] E. Jordanova,et al. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] P. Leboit. Pathology and genetics of skin tumours , 2006 .
[71] C. Massone,et al. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. , 2005, Blood.
[72] Nicola Pimpinelli,et al. WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.
[73] G. Wood,et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. , 2003, Human pathology.
[74] M. Piris,et al. Hydroa-Like Cutaneous T-Cell Lymphoma: A Clinicopathologic and Molecular Genetic Study of 16 Pediatric Cases from Peru , 2002, Applied immunohistochemistry & molecular morphology : AIMM.
[75] R. Willemze,et al. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. , 2002, Archives of dermatology.
[76] T. Okamura,et al. Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease. , 2001, Blood.
[77] K. Ohshima,et al. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. , 2001, Journal of the American Academy of Dermatology.
[78] C. Meijer,et al. Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment , 2000 .
[79] Akiba,et al. The association of latent Epstein–Barr virus infection with hydroa vacciniforme , 1999, The British journal of dermatology.
[80] C. Meijer,et al. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects. , 1992, The Journal of investigative dermatology.